Ledger.Open graph →
SEC Form D · Amendment · filed November 12, 2025

ZETAGEN THERAPEUTICS, INC

Offering
$13.0M
Sold
$12.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SYRACUSE, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Peter B. Finn · Boston, MAExecAshok C. Kaveeshwar · Bethesda, MDDirectorNikhil Thakur, Md · Andover, MAExec · DirectorDonald C. Brown · Hopkinton, MADirectorRichard C. Warburg · Bethesda, MDDirectorJoe C. Loy · Weatherford, TXExec · DirectorMichael J. Stark · Menlo Park, CADirectorHans Miller · Arlington, VAExecNicholas Bienstock · New York, NYExec · DirectorWilliam O. White · Baltimore, MDDirectorMichael D. Hankin · Baltimore, MDDirectorRobert Poulin · Arlington, VAExec · DirectorAndrew Levin · Boston, MAExecJoshua Resnick · Boston, MAExec · DirectorGregory M. Gentile · New York, NYExec · DirectorSteven Sordello · New York, NYDirectorTodd Crow · Portland, ORDirectorSteve Wolin · Minneapolis, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗